Pure Global

BIOPORT PLUS 1.5% Intra-articular Injection - Taiwan Registration 96a13d3bb45ec833828127ba3d794fca

Access comprehensive regulatory information for BIOPORT PLUS 1.5% Intra-articular Injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 96a13d3bb45ec833828127ba3d794fca and manufactured by MAXIGEN BIOTECH INC.. The authorized representative in Taiwan is MAXIGEN BIOTECH INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
96a13d3bb45ec833828127ba3d794fca
Registration Details
Taiwan FDA Registration: 96a13d3bb45ec833828127ba3d794fca
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

BIOPORT PLUS 1.5% Intra-articular Injection
TW: ็™พๅ„ช็Žป้—œ็ฏ€ๅ…งๆณจๅฐ„ๅŠ‘
Risk Class 3
MD

Registration Details

96a13d3bb45ec833828127ba3d794fca

Ministry of Health Medical Device Manufacturing No. 007514

Company Information

Taiwan, Province of China

Product Details

Details are as detailed as approved Chinese instructions

N Orthopedics

N0003 Hyaluronic acid implants for the joint cavity

Produced in Taiwan, China

Dates and Status

Jul 26, 2022

Jun 30, 2028